- Q1 2024 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 07, 2024MXN1251.41Earnings
- Q4 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptFeb 22, 2024MXN1020.67Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Intra-Cellular Therapies Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 02, 2023MXN1135.67Earnings
- Intra-Cellular Therapies Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Intra-Cellular Therapies Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 03, 2023MXN1135.67Earnings
- Intra-Cellular Therapies Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Intra-Cellular Therapies Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Intra-Cellular Therapies Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 04, 2023MXN1135.67Earnings
- Intra-Cellular Therapies Inc LUMATEPERONE Study 403 Topline Results TranscriptMar 28, 2023
- Q4 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptMar 01, 2023MXN987.74Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 03, 2022Earnings
- Q2 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 09, 2022Earnings
- Q1 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 10, 2022Earnings
- Q4 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptMar 01, 2022Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 09, 2021Earnings
- Intra-Cellular Therapies Inc to Feature Highlights of Several of its Development Programs TranscriptOct 20, 2021
- Q2 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 09, 2021Earnings
- Intra-Cellular Therapies Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Intra-Cellular Therapies Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 10, 2021Earnings
- Intra-Cellular Therapies Inc Investor Webcast on Lumateperone Programs TranscriptMay 04, 2021
- Q4 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptFeb 25, 2021Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Q3 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 09, 2020Earnings
- Intra-Cellular Therapies Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Intra-Cellular Therapies Inc to Discuss Positive Topline Results from Study 402 - Conference Call TranscriptSep 09, 2020
- Q2 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 10, 2020Earnings
- Q1 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 07, 2020Earnings
- Q4 2019 Intra-Cellular Therapies Inc Earnings Call TranscriptMar 02, 2020Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 05, 2019Earnings
- Intra-Cellular Therapies, Inc. - Special Call TranscriptAug 05, 2019
- Intra-Cellular Therapies Inc to Discuss the Top-line Results of Studies 401 and 404 Call TranscriptJul 08, 2019
- Q1 2019 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 08, 2019Earnings
Intra-Cellular Therapies Inc to Discuss the Top-line Results of Studies 401 and 404 Call Transcript
Good morning, ladies and gentlemen, and welcome to the Intra-Cellular Therapies conference call. (Operator Instructions)
I would now like to hand the call over to Dr. Juan Sanchez, Vice President, Corporate Communications and Investor Relations. You may begin.
Thank you, operator. Good morning and thank you all for joining us on today's conference call to discuss the topline results from Study 404 and 401, our 2 studies evaluating lumateperone as monotherapy in patients with bipolar depression. Our press release announcing the results crossed the wire a short time ago and is available on our website at intracellulartherapies.com.
Joining me on the call today are Dr. Sharon Mates, Chairman and CEO; Dr. Andrew Satlin, Executive Vice President and Chief Medical Officer; Dr. Kimberly Vanover, Senior Vice President of Early Stage Clinical Development and Translational Medicine; and Michael Halstead, Executive Vice President and General Counsel.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)